After testing dust from in the air near large-scale feedlots on the Southern High Plains, scientists found evidence of antibiotics, feedlot-derived bacteria and DNA sequences that encode for antibiotic resistance.
Scientists are seeking to find out the different processes used by bacteria to survive destruction from antimicrobial peptides within the natural environment. The hope is to find new ways to kill pathogenic organisms.
The challenge faced by scientists in developing a new generation of antibiotics to challenge the menace of antibiotic resistant superbugs is considerable. To help with this, researchers have pinpointed the how resistance develops.
A British government-commissioned review has found that resistance to antibiotics could account for 10 million deaths a year and hit global gross domestic product by 2.0 to 3.5 percent by 2050.
Across the U.K., over 8,100 healthcare professionals and some 3,600 members of the public have pledged to do their own part to help reduce antibiotic resistance by becoming “antibiotic guardians.”
Technologists and biologists have combined resources to use computer simulations to show how bacteria are able to destroy antibiotics. This combination approach could lead to the development of a new generation of drugs.
If a patient contracts an infection while in the hospital, then each day of hospitalization increases the likelihood that the infection will be antibiotic resistant by one percent. This alarming finding comes from a new study.
There are fears that national guidelines in the U.K. to reduce inappropriate prescribing of antibiotics in primary care have failed dramatically in relation to treatment of the common cold, according to a new study.
London Colney -
Antibacterial resistance is a growing global problem. According to the most recent statistics from the CDC, at least 2 million people acquire serious infections with bacteria that are resistant to one or more of antibacterial drugs.
During the 2013 flu season a new report highlights that antibiotics were inappropriately given to a large proportion of patients with influenza (a viral disease that is not helped by taking antibiotics).
A new approach in tackling and destroying antibiotic resistant bacteria is being considered. New research reveals an Achilles' heel in the defensive barrier that surrounds drug-resistant bacterial cells.
Antibiotics kill pathogenic bacteria. However, they can also kill beneficial bacteria and upset the human body, especially in the gut. Scientists have developed a way to help protect ‘good’ bacteria from antibiotics.